Fen-Z
Latest round
- Series B
Last raised
- Jan 2021
Total raised
- $15M
Investors
- 5
About Fen-Z
Fen-Z, founded in 2012 in Beijing, China, develops molecular interaction technologies.Fen-Z specializes in the development and delivery of innovative molecular interaction solutions aimed at addressing complex challenges in various scientific and industrial applications. Their core product offerings focus on advanced biochemical analysis tools, which are utilized primarily in research laboratories and pharmaceutical companies for drug discovery and development processes. These offerings enable clients to gain insights into molecular behaviors, optimize compound interactions, and expedite the R&D cycle.Fen-Z generates revenue through a structured model that includes direct sales of its flagship biochemical analysis tools, alongside potential subscription-based access to its proprietary software for data analysis and interpretation. Clients typically engage in purchasing equipment and software packages tailored to their specific research needs, reflecting B2B dynamics. For instance, a pharmaceutical company may procure a set of instruments that include comprehensive support and software solutions, facilitating streamlined integration into their existing laboratory workflows. The company is currently designing new advanced biochemical analysis tools, with anticipated launches over the next 18 months. Additionally, Fen-Z aims to enter the European and North American markets more aggressively by 2023, further establishing its presence in these regions.
Who invested in Fen-Z
5 investors across 4 rounds
See all investors in Fen-Z
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Fen-Z
Who invested in Fen-Z?
Fen-Z has 5 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Fen-Z raised?
Fen-Z has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Fen-Z last raise money?
Fen-Z's most recent round on record is a Series B, in Jan 2021.
What does Fen-Z do?
Fen-Z, founded in 2012 in Beijing, China, develops molecular interaction technologies.
Where is Fen-Z headquartered?
Fen-Z is headquartered in Beijing, China.
Which VCs invest in companies like Fen-Z?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back marketing/advertising companies at Fen-Z's stage. Their profiles are linked below.
VCs backing marketing/advertising startups at Series B
Raising like Fen-Z? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.